BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24155403)

  • 1. NF-κB activation coordinated by IKKβ and IKKε enables latent infection of Kaposi's sarcoma-associated herpesvirus.
    He Z; Zhao J; Zhang J; Jung JU; Feng P
    J Virol; 2014 Jan; 88(1):444-55. PubMed ID: 24155403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IKK epsilon kinase is crucial for viral G protein-coupled receptor tumorigenesis.
    Wang Y; Lu X; Zhu L; Shen Y; Chengedza S; Feng H; Wang L; Jung JU; Gutkind JS; Feng P
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11139-44. PubMed ID: 23771900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.
    Sadagopan S; Sharma-Walia N; Veettil MV; Raghu H; Sivakumar R; Bottero V; Chandran B
    J Virol; 2007 Apr; 81(8):3949-68. PubMed ID: 17287275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
    Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. vFLIP upregulates IKKε, leading to spindle morphology formation through RelA activation.
    Yang Z; Honda T; Ueda K
    Virology; 2018 Sep; 522():106-121. PubMed ID: 30029010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
    Gutierrez KD; Morris VA; Wu D; Barcy S; Lagunoff M
    J Virol; 2013 Jun; 87(12):6758-68. PubMed ID: 23552426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε.
    Liang D; Gao Y; Lin X; He Z; Zhao Q; Deng Q; Lan K
    Cell Res; 2011 May; 21(5):793-806. PubMed ID: 21221132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
    Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
    PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65.
    Hävemeier A; Gramolelli S; Pietrek M; Jochmann R; Stürzl M; Schulz TF
    J Virol; 2014 Nov; 88(22):13161-72. PubMed ID: 25187543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC.
    Matta H; Gopalakrishnan R; Graham C; Tolani B; Khanna A; Yi H; Suo Y; Chaudhary PM
    PLoS One; 2012; 7(5):e36601. PubMed ID: 22590573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
    King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
    J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency.
    Ye FC; Zhou FC; Xie JP; Kang T; Greene W; Kuhne K; Lei XF; Li QH; Gao SJ
    J Virol; 2008 May; 82(9):4235-49. PubMed ID: 18305042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection.
    Lee MS; Jones T; Song DY; Jang JH; Jung JU; Gao SJ
    PLoS Pathog; 2014 Sep; 10(9):e1004412. PubMed ID: 25254972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.
    Chen M; Sun F; Han L; Qu Z
    Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.